These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response. Duan L; Wang CY; Chen J; Gong Q; Zhu P; Zheng F; Tan Z; Gong F; Fang M Lab Invest; 2011 Jan; 91(1):43-53. PubMed ID: 20714327 [TBL] [Abstract][Full Text] [Related]
3. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation. Liang Y; Christopher K; Finn PW; Colson YL; Perkins DL Transplantation; 2007 Sep; 84(6):771-7. PubMed ID: 17893611 [TBL] [Abstract][Full Text] [Related]
4. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279 [TBL] [Abstract][Full Text] [Related]
6. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563 [TBL] [Abstract][Full Text] [Related]
7. Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection. Chen X; Zhao S; Tang X; Ge H; Liu P Mol Vis; 2011; 17():2148-56. PubMed ID: 21850190 [TBL] [Abstract][Full Text] [Related]
8. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients. Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661 [TBL] [Abstract][Full Text] [Related]
9. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684 [TBL] [Abstract][Full Text] [Related]
10. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody. Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472 [TBL] [Abstract][Full Text] [Related]
11. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314 [TBL] [Abstract][Full Text] [Related]
12. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. Yuan X; Paez-Cortez J; Schmitt-Knosalla I; D'Addio F; Mfarrej B; Donnarumma M; Habicht A; Clarkson MR; Iacomini J; Glimcher LH; Sayegh MH; Ansari MJ J Exp Med; 2008 Dec; 205(13):3133-44. PubMed ID: 19047438 [TBL] [Abstract][Full Text] [Related]
13. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865 [TBL] [Abstract][Full Text] [Related]
14. Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Diaz JA; Booth AJ; Lu G; Wood SC; Pinsky DJ; Bishop DK Am J Transplant; 2009 Aug; 9(8):1773-83. PubMed ID: 19538487 [TBL] [Abstract][Full Text] [Related]
15. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872 [TBL] [Abstract][Full Text] [Related]
16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
17. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human IL-37 attenuates acute cardiac allograft rejection in mice. Shao B; Zhang JY; Ren SH; Qin YF; Wang HD; Gao YC; Kong DJ; Hu YH; Qin H; Li GM; Wang H Cytokine; 2024 Jul; 179():156598. PubMed ID: 38583255 [TBL] [Abstract][Full Text] [Related]